Dr. Banks joined Achillion in 2013, leading all Chemical Manufacturing & Control (CMC) activities and later taking on additional responsibility to include quality assurance and compliance. Dr. Banks has over 30 years of experience in pharmaceutical research and development. His career has included 27 years with Pfizer in the UK and USA encompassing various functions and increasing levels of responsibility in CMC. Prior to Pfizer, Dr. Banks was head of formulation development within the International Development Centre of Abbott Laboratories, UK. He has a wealth of experience progressing compounds from early development through to successful, global regulatory approvals and commercialization.
He is a pharmacist and graduated from Leicester School of Pharmacy with a BSc (Hons) Pharmacy degree and a PhD in Pharmaceutical Technology. He later earned a MBA with distinction from University of Kent in the UK.